We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Argenta Discovery and PRECOS Establish Cancer Drug Discovery Alliance
News

Argenta Discovery and PRECOS Establish Cancer Drug Discovery Alliance

Argenta Discovery and PRECOS Establish Cancer Drug Discovery Alliance
News

Argenta Discovery and PRECOS Establish Cancer Drug Discovery Alliance

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Argenta Discovery and PRECOS Establish Cancer Drug Discovery Alliance"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Argenta Discovery and PRECOS announced they have entered into an alliance to provide exceptional cancer drug discovery services and expertise on a fee-for-service basis.

The collaboration enables Argenta and PRECOS to undertake complete, integrated oncology-focused drug discovery programmes for their contract research clients, from hit finding to in vivo ‘proof-of-concept’.

Dr. Christopher Ashton, Chief Executive Officer of Argenta Discovery said, "Argenta has undertaken many successful medicinal chemistry-driven cancer drug discovery contract research projects in the past, but we have been looking at ways of enhancing our capabilities in this therapeutic area, where there is still considerable unmet medical need. Argenta has partnered with PRECOS to provide clients with dedicated access to specialist in vitro, ex vivo and in vivo cancer models and expertise, offered by a world leader in the field.”

“We have several ongoing cancer-focused contract research programmes and a number of projects in the pipeline which are likely to benefit from PRECOS’ support and know-how. This alliance will enable Argenta to offer an even better integrated drug discovery service in the future. We are looking forward to working with PRECOS.”
Advertisement